These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9081723)

  • 1. [Polymyositis/dermatomyositis and autoantibodies].
    Hirakata M; Mitsumori K; Akizuki M
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Dec; 19(6):588-93. PubMed ID: 9081723
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis.
    Roux S; Seelig HP; Meyer O
    J Rheumatol; 1998 Feb; 25(2):395-6. PubMed ID: 9489847
    [No Abstract]   [Full Text] [Related]  

  • 3. [Laboratory diagnostics of polymyositis/dermatomyositis].
    Prus V; Bedeković D
    Reumatizam; 2012; 59(2):27-30. PubMed ID: 23745451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary lesion in polymyositis and dermatomyositis].
    Bondarenko IB; Mukhin NA; Nasonov EL; Kornev BM; Shtutman VZ; Guseva NG
    Klin Med (Mosk); 1998; 76(2):20-4. PubMed ID: 9553354
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and pathological investigation of polymyositis and dermatomyositis: report of 83 cases].
    Li Q; Lu BX; Zhou L; An SL
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1139-40. PubMed ID: 12480599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
    Cherin P
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleromyositis (scleroderma/polimyositis overlap) is an entity.
    Jablonska S; Blaszyk M
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):265-6. PubMed ID: 15096133
    [No Abstract]   [Full Text] [Related]  

  • 8. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells.
    Fasth AE; Dastmalchi M; Rahbar A; Salomonsson S; Pandya JM; Lindroos E; Nennesmo I; Malmberg KJ; Söderberg-Nauclér C; Trollmo C; Lundberg IE; Malmström V
    J Immunol; 2009 Oct; 183(7):4792-9. PubMed ID: 19752224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyositis and dermatomyositis: pathophysiology.
    Nagaraju K; Lundberg IE
    Rheum Dis Clin North Am; 2011 May; 37(2):159-71, v. PubMed ID: 21444017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of anti-Ro52α and anti-Ro52β antibodies in dermatomyositis/polymyositis.
    Ogawa-Momohara M; Muro Y; Mitsuma T; Katayama M; Yanaba K; Nara M; Kakeda M; Akiyama M
    J Dermatol Sci; 2019 Oct; 96(1):50-52. PubMed ID: 31444014
    [No Abstract]   [Full Text] [Related]  

  • 11. Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis.
    Aleksza M; Szegedi A; Antal-Szalmás P; Irinyi B; Gergely L; Ponyi A; Hunyadi J; Sipka S; Zeher M; Szegedi G; Dankó K
    Ann Rheum Dis; 2005 Oct; 64(10):1485-9. PubMed ID: 15829578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polymyositis and dermatomyositis in adults].
    Matsubara S
    Ryoikibetsu Shokogun Shirizu; 2001; (35):284-90. PubMed ID: 11555932
    [No Abstract]   [Full Text] [Related]  

  • 13. Humoral immunity in polymyositis and dermatomyositis.
    Targoff IN; Reichlin M
    Mt Sinai J Med; 1988 Nov; 55(6):487-93. PubMed ID: 3068537
    [No Abstract]   [Full Text] [Related]  

  • 14. Polymyositis-dermatomyositis and infections.
    Zampieri S; Ghirardello A; Iaccarino L; Briani C; Sarzi-Puttini P; Atzeni F; Arienti S; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):191-6. PubMed ID: 16769652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunological aspects of polymyositis].
    Takayanagi T; Honda H
    No To Shinkei; 1983 Jun; 35(6):525-33. PubMed ID: 6354219
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neopterin: marker of cellular immunity activation in idiopathic inflammatory myopathy].
    Nasonov EL; Samsonov MI; Shtutman VZ; Gekht BM; Gurkina GT; Tilz GP; Guseva NG; Fuchs D; Wachter H
    Klin Med (Mosk); 1997; 75(2):47-51. PubMed ID: 9157218
    [No Abstract]   [Full Text] [Related]  

  • 17. [Importance of specific IgA antibodies in the diagnosis of active toxoplasmosis associated to polymyositis/dermatomyositis].
    Arcavi M; Troielli P; Pizzimenti MC; Griemberg G
    Medicina (B Aires); 2005; 65(2):183-4. PubMed ID: 16075821
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
    Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
    Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
    Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
    Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunopathology and treatment of polymyositis and dermatomyositis].
    Hase A; Arahata K
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):664-9. PubMed ID: 9627475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.